Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1349studies shown
Showing 351-375 of 1,349
OngoingEUCTR 2020-002196-35

post-trial access cohort BUmetanide for Developmental DIsorders

This observational study is following people with Neurodevelopmental disorders Autism spectrum disorder Attention deficit hyperactivity disorder Learning disorders or Children, Adolescents, Under 18 to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

ADHDOther
Countries
Netherlands
Sponsor
Amsterdam UMC, location VUmc
Condition
ADHD
OngoingEUCTR 2012-000492-17

The Effects of Long-acting Methylphenidate on Academic Activity and Related Constructs in Children with ADHD: A Randomised Placebo Controlled Trial

This study is looking at whether METHYLPHENIDATE HYDROCHLORIDE can help people with Attention-deficit hyperactivity disorder or Children, Adolescents, Under 18. Participants receive the study medicine METHYLPHENIDATE HYDROCHLORIDE and complete study visits and assessments.

ADHDOther
Countries
Netherlands
Sponsor
Afdeling Klinische Neuropsychologie Vrije Universiteit Amsterdam
Condition
ADHD
OngoingEUCTR 2009-012261-61

Why methylphenidate is not successful in cocaine-dependent ADHD patients: a SPECT study comparing DAT before and after methylphenidate treatment in ADHD patients with and without cocaine dependence

This study is looking at whether METHYLPHENIDATE can help people with ADHD with and without substance use disorder. Participants receive the study medicine METHYLPHENIDATE and complete study visits and assessments.

ADHDOther
Countries
Netherlands
Sponsor
Academic Medical Center
Condition
ADHD
OngoingEUCTR 2014-005045-53

Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit...

This study is looking at whether METHYLPHENIDATE can help people with Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivit. Participants receive the study medicine METHYLPHENIDATE and complete study visits and assessments.

ADHDOther
Countries
Sweden
Sponsor
Landstinget Västmanland
Condition
ADHD
OngoingEUCTR 2009-011887-12

Evaluation of ADHD from childhood to adolescence- impact of medical treatment on autonomic nervous system parameters

This study is looking at whether Methylphenidate compared with Atomoxetine can help people with ADHD is a neurobehavioral developmental disorder which affects about 5% of children. In our clinical trial designed we would like to examine whether medical treatment with stimulants has an influen or Children, Adolescents, Under 18.

ADHDOther
Countries
Germany
Sponsor
Praxis Prof. Koenig
Condition
ADHD
OngoingEUCTR 2013-004776-35

Cross-sectional study of 24-hour ambulatory blood pressure measurements and left ventricular mass using echocardiograms in late adolescents and adults with ADHD (ADDUCE protocol WP8 (cardiovascular))

This study is looking at whether Methylphenidate can help people with Cardiovascular functioning in Attention deficit hyperactivity disorder following 3 years of treatment with methylphenidate or Adolescents, Under 18. Participants receive the study medicine Methylphenidate and complete study visits and assessments.

ADHDOther
Countries
United Kingdom
Sponsor
Radboud University Medical Centre Nijmegen
Condition
ADHD
OngoingEUCTR 2017-001490-16

Lisdexamphetamine treatment of Bulimia Nervosa with and without probable simultaneous Attention Deficit Hyperactivity Disorder (ADHD). A randomized , open, fase II-study with cross-over design.

This study is looking at whether lisdexamfetamine dimesylate can help people with Bulimia Nervosa with and without simultaneous Attention Deficit Hyperactivity Disorder. Participants receive the study medicine lisdexamfetamine dimesylate and complete study visits and assessments.

ADHDOther
Countries
Sweden
Sponsor
Stockholms läns landsting
Condition
ADHD
OngoingEUCTR 2010-020508-31

Hersengymnastiek? Sport en neurofeedback als behandeling voor ADHD.

This study is looking at whether Medikinet CR, 10, 20, 30 en 40 mg, capsules met verlengde afgifte, hard. can help people with Attention Deficit Hyperactivty Disoerder or Children, Adolescents, Under 18.

ADHDOther
Countries
Netherlands
Sponsor
ZonMw zorg voor jeugd-effecten en kosten
Condition
ADHD
OngoingEUCTR 2007-001855-20

A double blind placebo controlled crossover study to determine the effects of atomoxetine on event-related potentials in response to auditory oddball stimuli during an on-the-road driving test in a...

This study is comparing Atomoxetine hydrochloride with placebo for people with The effects of atomoxetine on driving performance, attention and response inbihition are studied in with attention-deficit hyperactivity disorder. Participants receive Atomoxetine hydrochloride or placebo and complete study visits and assessments.

ADHDOther
Countries
Netherlands
Sponsor
Faculty of Social Sciences, Utrecht University
Condition
ADHD
OngoingEUCTR 2016-002875-81

Bumetanide for the Autism Spectrum Clinical Effectiveness Trial

This study is looking at whether Bumetanide can help people with Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Epilepsy or Children, Adolescents, Under 18. Participants receive the study medicine Bumetanide and complete study visits and assessments.

ADHDOther
Countries
Netherlands
Sponsor
UMC Utrecht
Condition
ADHD
TerminatedNCT01506232

Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolarity, or Autism Spectrum Disorders: A Preliminary Study

This study exists to understand what helps questionnaires and follow-up reports work in everyday practice, not just under ideal conditions. Researchers are trying to understand what questionnaires and follow-up reports can reveal about signals in the brain or body that may guide care later on.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
CompletedNCT01931644

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

ADHDOtherFrom 18 Years to 100 Years
Countries
United States
Sponsor
Sanguine Biosciences
Condition
ADHD
CompletedNCT02478788

Neuroimaging Study of Risk Factors for Adolescent Bipolarity

This study exists to see whether the medication Risk can play a useful role in care. Researchers are trying to understand whether the medication Risk can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 10 Years to 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity
CompletedNCT05601063

Ascertaining Diagnosis Classification With Elicited Speech

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 14 Years to 50 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
WithdrawnNCT03842345

DELPhI Evaluation of Psychiatric Conditions

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

DepressionOtherOver 18 Years
Countries
Global
Sponsor
QuantalX Neuroscience
Condition
Depression
CompletedNCT03292848

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Not Yet RecruitingNCT07540585

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 100 Years
Countries
United States
Sponsor
Indiana University
Condition
Depression